Fasting-mimicking diet
Fasting-mimicking diet has been studied in 157 papers since 2015: 47 trials and 2 observational studies in people, 39 in animals, 1 in cells, 62 reviews; 30 in the past year. The newest paper, Nov 4, 2026: “From Fasting to Caloric Restriction: State of the Art and Clinical Implications”.
InterventionDietary restriction
157 papers study it307 findingsUpdated
3 new papers in 30 daysSee all 153 papers on fasting-mimicking diet
At a glance
A human trial reports lower biological age with a fasting-mimicking diet; independent labs report lower IGF-1 in humans and inflammation in mice. Human body-weight results include decreases and no clear effects. L-Nutra sponsors the registered aging trial, which is not completed, and 11 of 43 human papers declare ties to this developer.
307 findings in 96 papers from 2015 to 2026, 4 of them since June 2026
Independent labs found the same change in mice and people. 37 independent labs in 14 countries; 1 trial, 1 about aging.
“there was no difference in toxicity between both groups”
11 of its findings point the other way.
- 37 independent labs in 14 countries
- 11 findings against
- 1 trial, 1 about aging
- Funders: National Institute on Aging and others
- 85 of 269 findings with company ties
- 1 of 1 trial sponsored by its developers
- Human trial46
- Humans2
- Animals36
- Cells1
- In silico3
Studies in people
See all 36 studies of fasting-mimicking diet in people36 studies gave fasting-mimicking diet to people and measured what changed.
| What changed | Design | People | Source |
|---|---|---|---|
down: Decreases glucose4.7 mmol/L to 4.0 mmol/L down: Decreases IGF-123 nmol/L to 17.9 nmol/L up: Increases ketonenear zero to median 1.86 mmol/L | Trialtwo cycles of a 4-day FMD separated by 3 weeks of regular diet | 9 peopleHealthy volunteers | Nutrients, Aug 3, 2026 |
down: Decreases left ventricular massmean difference, -5.47 g up: Improves early-to-late peak filling ratiomean difference, 0.27 up: Improves mitral annular early peak velocitymean difference, 0.84 cm/sec | Randomized trial6 months | 82 peopleBothmean age, 62.9 years ± 8.5Older adults; in individuals with type 2 diabetes | Radiology. Cardiothoracic imaging, Jul 30, 2026 |
up: Improves clinical response69.2% FMD versus 43.8% control up: Improves clinical remission64.6% FMD versus 37.5% control down: Decreases calprotectin−22.0% versus 8.0% | Randomized trialthree months | 97 peoplemedian age 45.0 years (IQR 35.0 to 55.0)Patients with mild-to-moderate Crohn's disease | Nature medicine, Jan 13, 2026 |
down: Decreases body weight down: Decreases fasting glucose down: Decreases HOMA-IR | Randomized trial8 days | 30 people83.3% were femalemean age of 49.1 ± 11.8 yearsParticipants recruited from the San Antonio, Texas USA community | GeroScience, Dec 11, 2025 |
no change: Has no effect on quality of lifeunadjusted mean difference −0.04, 95% CI −0.10 to 0.03 | Randomized trialone year | 92 peoplePatients with type 2 diabetes | BMC primary care, Nov 10, 2025 |
What did studies of fasting-mimicking diet find?
193Studies of fasting-mimicking diet measured 193 outcomes; the most studied are body weight (12 studies), IGF-1 (8) and inflammation (7).
Body weight
downin humans8downin mice2no changein humans1downin reviews1
12 studies
Body weight
downin humans8downin mice2no changein humans1downin reviews1
Fasting-mimicking diet decreases body weight in humans.
“Significant differences from baseline to the end of the dietary intervention at 6 days were observed between treatment groups, with an increase in β-hydroxybutyrate and decreases in weight, fasting glucose, insulin, and HOMA-IR in the FMD groups compared to the control group.”
Human trial8 daysn = 30
Effect of fasting-mimicking diet on markers of autophagy and metabolic health in human subjects
GeroScience
Fasting-mimicking diet decreases body weight in humans.
“explore the effects of FMDs on the human salivary metabolic profiles and weight in a single-arm case study”
Human trial
bioRxiv (Cold Spring Harbor Laboratory)Preprint
Fasting-mimicking diet decreases body weight in humans (adjunct to usual care in type 2 diabetes) (-3.6 kg; 95% CI -5.2, -2.1).
“and body weight (-3.6 kg; 95% CI -5.2, -2.1; p<0.001) at 12 months.”
Human trialadjunct to usual care in type 2 diabetes5-day cycles monthly12 months
Diabetologia
Fasting-mimicking diet decreases body weight in humans (−3.6 kg (95% CI −5.2, −2.1)).
“There was a significant adjusted estimated treatment effect on body weight (−3.6 kg; 95% CI −5.2, −2.1; p<0.001), BMI (−1.2 kg/m2; 95% CI −1.7, −0.7; p<0.001), waist circumference (−3.5 cm; 95% CI −5.3, −1.6; p<0.001) and body fat percentage (−2.2%; 95% CI −3.3, −1.0; p<0.001) at 12 months”
Human trial12 monthsn = 100
Diabetologia
Fasting-mimicking diet decreases body weight in hypertensive patients with obesity/excess weight.
“Both FMD and MD led to comparable decreases in weight, waist circumference, BMI, body fat mass and % body fat, total cholesterol, and leptin.”
Human trialin hypertensive patients with obesity/excess weight4 months
npj metabolic health and disease
Fasting-mimicking diet decreases body weight in humans (obesity hypoventilation syndrome) (considerably reduced).
“Also, the mimic diet group's weight and neck circumference were considerably reduced after the intervention, with no change in the reflexology group.”
Human trialobesity hypoventilation syndrometwo monthsmales
Journal of complementary & integrative medicine
Fasting-mimicking diet decreases body weight in humans (prostate cancer with features of metabolic syndrome) (-3.79 kg (95% CI: -5.61, -1.97, p = 0.0002)).
“On average patients' weights dropped by 3.79 kg (95% CI: -5.61, -1.97, p = 0.0002).”
Human trialprostate cancer with features of metabolic syndromen = 29
Prostate cancer and prostatic diseases
Fasting-mimicking diet decreases body weight in humans.
“The average weight loss in the FMD group after 5 days of the dietary intervention was 2.8 ± 0.2 kg of body weight.”
Human trial5 days
Nutrients
Fasting-mimicking diet decreases body weight in humans (-2.8 ± 0.2 kg).
“Moreover, FMD led to a weight loss of 2.8 ± 0.2 kg and a subsequent reduction in BMI compared to baseline.”
Human trial5-dayn = 24
Nutrients
Fasting-mimicking diet showed no clear effect on body weight in humans (metabolically healthy women with obesity) (-2.29 (1.95) kg vs -1.13 (2.27) kg, p = 0.06).
“There was no significant difference in weight loss between the two groups: mean weight change for CER was - 2.29 (standard deviation [SD], 1.95) kg compared to - 1.13 (2.27) kg for FMD (p = 0.06).”
Human trialmetabolically healthy women with obesity2 monthsfemalesn = 60
Obesity surgery
All 14Fewer
IGF-1
downin humans8
8 studies
IGF-1
downin humans8
Fasting-mimicking diet decreases IGF-1 in humans (23 nmol/L to 17.9 nmol/L).
“Similarly, IGF-1 plasma levels decreased over time (p = 0.029) with the fed state 23 nmol/L (median, IQR 19.6–30.3) and FMD-fasted 17.9 nmol/L (median, IQR 12.4–27.6) showing the largest difference (p = 0.028; ).”
Human trialn = 9
Nutrients
Fasting-mimicking diet decreases IGF-1 in humans (healthy individuals).
“FMD was associated with reduced plasma glucose and insulin-like growth factor-1”
Human trialhealthy individualstwo cycles of a 4-day FMD separated by 3 weeks of regular dietn = 6
Nutrients
Fasting-mimicking diet decreases IGF-1 in humans (at the end of the first and second FMD cycles; not significant at the third) (B = -23.29, p = 0.001 (first FMD); B = -16.20, p = 0.023 (second FMD)).
“A decline in IGF-1 compared to baseline was observed to be statistically significant at the end of the first FMD”
Human trialat the end of the first and second FMD cycles; not significant at the thirdrecipe-based34-54% of normal caloric intakethree FMD cycles
Breast cancer research and treatment
Fasting-mimicking diet decreases IGF-1 in humans.
“Compared with T0, IGF-1 decreased significantly at T2 and T4, with p = 0.001 and p = 0.023 respectively.”
Human trialthree cycles of the 5-day FMDfemalesn = 30
Breast cancer research and treatment
Fasting-mimicking diet decreases IGF-1 in humans during neoadjuvant chemotherapy (p = 0.006).
“the median Insulin-like growth factor-1 (IGF1) (p = 0.006) and hs-CRP (p = 0.02) levels were significantly decreased in the FMD group”
Human trialduring neoadjuvant chemotherapy
Frontiers in nutrition
Fasting-mimicking diet decreases IGF-1 in humans (between baseline and after cycle 8).
“On the other hand, the median levels of IGF-1 and hs-CRP was significantly decreased in FMD group between the two-time points (p = 0.006 and p = 0.02 respectively).”
Human trialbetween baseline and after cycle 83 days before to and on the day of each cycle of chemotherapy
Frontiers in nutrition
Fasting-mimicking diet decreases IGF-1 in humans (-37 ± 8 ng/mL).
“We also observed a significant reduction in plasma insulin-like growth factor-1 (IGF-1) concentrations ( B) in the FMD group by 37 ± 8 ng/mL, which was not present in the VEG diet group.”
Human trial5 days
Nutrients
Fasting-mimicking diet decreases IGF-1 in cancer patients undergoing active treatment.
“FMD reduced the serum c-peptide, IGF1, IGFBP3 and leptin levels”
Human trialin cancer patients undergoing active treatment
Cancers
Fasting-mimicking diet decreases IGF-1 in patients with hormone-receptor-positive breast cancer receiving estrogen therapy.
“cycles of a fasting-mimicking diet cause metabolic changes analogous to those observed in mice, including reduced levels of insulin, leptin and IGF1”
Human trialin patients with hormone-receptor-positive breast cancer receiving estrogen therapy
Fasting-mimicking diet and hormone therapy induce breast cancer regression
Nature
Fasting-mimicking diet decreases IGF-1 in humans (-21.7 ± 46.2 ng/ml).
“In conclusion, three cycles of the FMD reduced body weight, trunk and total body fat, blood pressure, and IGF-1 in comparison to a normal diet.”
Human trial3 monthsn = 100
Science translational medicine
All 12Fewer
Inflammation
downin mice4downin reviews2downin humans1
7 studies
Inflammation
downin mice4downin reviews2downin humans1
Fasting-mimicking diet inhibits inflammation in humans.
“The between-group analysis found that FMD->Control participants after six FMD cycles displayed a significant (p < 0.016) reduction in serum leptin levels, insulin, glucose, total cholesterol, LDL, CRP, AST and ALT, and HOMA-IR and an increase in ghrelin serum levels and HOMA %S with respect to Control->FMD subjects after 6 months on the control diet”
Human trial6 monthly cycles5 consecutive days each month for 6 monthsn = 102
Cell reports. Medicine
Fasting-mimicking diet decreases inflammation.
“suppress inflammation”
Review
Nutrition reviews
Fasting-mimicking diet decreases inflammation in DSS-induced colitis.
“FMD showed the most consistent beneficial impact.”
Animalsin DSS-induced colitiscolonmales
Restrictive diets have a beneficial impact on dextran sodium sulfate-induced colitis in male mice
The Journal of nutrition
Fasting-mimicking diet decreases inflammation in both cancer models treated with immune checkpoint inhibitors.
“immune infiltration of CD3+ and CD8+ cells in myocardial tissues and systemic and myocardial markers of oxidative stress and inflammation are reduced.”
Animalsin both cancer models treated with immune checkpoint inhibitorsmyocardial tissues
Nature communications
Fasting-mimicking diet decreases inflammation in animal models of AD.
“FMDs can reduce amyloid-beta accumulation, tau phosphorylation, and inflammation, as well as improve cognitive function in animal models of AD.”
Reviewin animal models of AD
Biomolecules
Fasting-mimicking diet inhibits inflammation in MPTP-induced PD mice.
“FMD also inhibited neuro-inflammation”
Animalsin MPTP-induced PD mice
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Fasting-mimicking diet decreases inflammation in chronic dextran sodium sulfate (DSS)-induced murine model.
“These FMD cycles reduced intestinal inflammation, increased stem cell number, stimulated protective gut microbiota, and reversed intestinal pathology caused by DSS”
Animalsin chronic dextran sodium sulfate (DSS)-induced murine modelintestine4-day cycles
Cell reports
HbA1c
downin humans4
4 studies
HbA1c
downin humans4
Fasting-mimicking diet decreases HbA1c in humans (adjunct to usual care in type 2 diabetes) (-3.2 mmol/mol; 95% CI -6.2, -0.2).
“improves HbA1c despite the reduction in medication use”
Human trialadjunct to usual care in type 2 diabetes5-day cycles monthly12 months
Diabetologia
Fasting-mimicking diet decreases HbA1c in humans (−3.2 mmol/mol (95% CI −8.0, −2.0)).
“The HbA1c values decreased from 52.2 ± 9.3 mmol/mol (6.9 ± 0.8%) (mean ± SD) at baseline to 49.5 ± 8.2 mmol/mol (6.7 ± 0.8%) at 12 months in the FMD group, and increased from 53.7 ± 12.2 mmol/mol (7.1 ± 1.1%) to 53.8 ± 7.6 mmol/mol (7.1 ± 0.7%) in the control group, yielding adjusted estimated treatment effects of −3.2 mmol/mol (95% CI −8.0, −2.0) and −0.3% (95% CI −0.6, −0.0) (p=0.04; Table and Fig”
Human trialblood12 monthsn = 100
Diabetologia
Fasting-mimicking diet decreases HbA1c in humans (compared to baseline in hypertensive patients with obesity/excess weight) (p = 0.0059).
“FMD decreased HbA1c (p = 0.0059) and IGF-1 (p = 0.0427)”
Human trialcompared to baseline in hypertensive patients with obesity/excess weight4 months
npj metabolic health and disease
Fasting-mimicking diet decreases HbA1c in humans (6.47 ± 0.51% vs 7.50 ± 0.50%).
“The FPG was 5.25 ± 0.23 mmol/L in the experimental group and 6.27 ± 0.37 mmol/L in the control group, the 2hPG was 7.02 ± 2.27 mmol/L and 8.33 ± 0.89 mmol/L, respectively, and the HbA1c was 6.47 ± 0.51% and 7.50 ± 0.50%, respectively.”
Human trial4-monthn = 100
Oxidative medicine and cellular longevity
Fasting-mimicking diet decreases HbA1c in humans (type 2 diabetes).
“fasting blood glucose, 2-hour postprandial venous blood glucose, and glycosylated haemoglobin of the experimental group were all lower than those of the control group (P < 0.05)”
Human trialtype 2 diabetes4 monthsn = 100
Oxidative medicine and cellular longevity
Fasting-mimicking diet decreases HbA1c in humans (meta-analysis of 11 RCTs) (WMD = -8.589 mmol/mol, 95% CI: -12.389, -4.769).
“FMD significantly reduced glycated hemoglobin (HbA1c) (WMD = -8.589 mmol/mol, 95% CI: -12.389, -4.769)”
Reviewmeta-analysis of 11 RCTs
Diabetology & metabolic syndrome
Immune response
upin mice2upin humans1downin mice1
4 studies
Immune response
upin mice2upin humans1downin mice1
Fasting-mimicking diet activates immune response.
“Together, these data indicate that the FMD, alone or in combination with standard antitumor therapies, downregulates immunosuppressive myeloid cell subsets, while at the same time increasing effector cells with an activated phenotype.”
Human trialfive-day FMD followed by 16 to 23 days of refeedingn = 38
Cancer discovery
Fasting-mimicking diet activates immune response in humans.
“paralleled by enhanced intratumor Th1/cytotoxic responses”
Human trialn = 101
Cancer discovery
Fasting-mimicking diet activates immune response in mouse colorectal cancer model.
“increased tumor-infiltration lymphocytes especially CD8+T cells”
Animalsin mouse colorectal cancer model4-day
Fasting-mimicking diet remodels gut microbiota and suppresses colorectal cancer progression
NPJ biofilms and microbiomes
Fasting-mimicking diet activates immune response in mice.
“FMD cycles enhance the efficacy of a range of drugs targeting different cancers in mice by stimulating antitumor immunity”
Review
Fasting and fasting mimicking diets in cancer prevention and therapy
Trends in cancer
Fasting-mimicking diet inhibits immune response in EAE mice.
“the mice using FMD had significant decreases in EAE severity, immune cell infiltration in spinal cord and CNS demyelination.”
Animalsin EAE micespinal cord
The Journal of nutritional biochemistry
Lifespan
upin mice2upin reviews2
4 studies
Lifespan
upin mice2upin reviews2
Fasting-mimicking diet extends lifespan in animal studies.
“In animal studies, FMD cycles promote stem cell activation, cellular reprogramming and autophagy leading to longevity extension”
Reviewin animal studies
Fasting Mimicking Diet Cycles, Regeneration, Biological Age, and Disease
GSA 2025 abstract
Fasting-mimicking diet extends lifespan.
“FMD not only extends the lifespan and reduces the incidence of cancer and other diseases in healthy individuals”
Review
The Role of Fasting-Mimicking Diet in Cancer Therapy: Mechanisms, Challenges, and Clinical Prospects
Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition
Fasting-mimicking diet extends lifespan in prematurely aging mice.
“FMD significantly prolonged the lifespan of prematurely aging mice.”
Animalsin prematurely aging mice
Fasting mimicking diet extends lifespan and improves intestinal and cognitive health
Food & function
Fasting-mimicking diet extends lifespan in mice.
“Bi-monthly FMD cycles started at middle age extended longevity, lowered visceral fat, reduced cancer incidence and skin lesions”
Animalsbi-monthly
Cell metabolism
Biological age
downin humans3
3 studies
Biological age
downin humans3
Fasting-mimicking diet decreases biological age in humans (-2.5 years).
“After 3 FMD cycles, median biological age in the 52 study participants decreased by nearly 2.5 years (Fig., p = 0.0007, Wilcoxon Rank Sum Scores ).”
Human trialthree cycles of this 5-day FMDn = 52
Nature communications
Fasting-mimicking diet decreases biological age in humans (independent of weight loss) (decrease of 2.5 years).
“3 FMD cycles were associated with a decrease of 2.5 years in median biological age, independent of weight loss.”
Human trialindependent of weight loss3 FMD cycles
Nature communications
Fasting-mimicking diet decreases biological age in humans (-2.5 years (P = 0.003)).
“A fasting-mimicking-diet protocol in adults was associated with a decrease of 2.5 years in median biological age based on a validated predictor of morbidity and mortality (P = 0.003)”
Review
Research Synthesis: Fasting Effects — full paper
OSF Preprints (OSF Preprints)Preprint
Fasting-mimicking diet decreases biological age in 2 different clinical trials (2.5 years).
“supported by a 2.5 years of biological age reduction associated with 3 FMD cycles in 2 different clinical trials”
Reviewin 2 different clinical trials3 FMD cycles
Fasting Mimicking Diet Cycles, Regeneration, Biological Age, and Disease
GSA 2025 abstract
HOMA-IR
downin humans3
3 studies
HOMA-IR
downin humans3
Fasting-mimicking diet decreases HOMA-IR in humans.
“Significant differences from baseline to the end of the dietary intervention at 6 days were observed between treatment groups, with an increase in β-hydroxybutyrate and decreases in weight, fasting glucose, insulin, and HOMA-IR in the FMD groups compared to the control group.”
Human trial8 daysn = 30
Effect of fasting-mimicking diet on markers of autophagy and metabolic health in human subjects
GeroScience
Fasting-mimicking diet decreases HOMA-IR in humans (-3.8 (-5.6, -2.0); P ≤ 0.05).
“FMD reduced HOMA-IR [-3.8 (-5.6, -2.0); P ≤ 0.05]”
Human trialmonthly6 monthsn = 40
The Journal of clinical endocrinology and metabolism
Fasting-mimicking diet decreases HOMA-IR in noninsulin treated participants (−3.8 (−5.6, −2.0), P ≤ 0.05).
“For the exploratory outcomes, we found that HOMA-IR decreased after 6 diet cycles [−3.8 −5.6, −2.0); P ≤ 0.05] in the noninsulin treated participants of FMD group compared to M-Diet.”
Human trialin noninsulin treated participants6 diet cycles
The Journal of clinical endocrinology and metabolism
Fasting-mimicking diet decreases HOMA-IR in all patients (-3.8 (95% CI -5.6, -2.0; P≤0.05)).
“FMD led to change in HOMA-IR of -3,8 (95% CI -5,6, -2.0; P≤0.05)”
Human trialin all patientssix monthsn = 40
medRxivPreprint
Cognitive function
upin mice2upin humans1upin reviews1
3 studies
Cognitive function
upin mice2upin humans1upin reviews1
Fasting-mimicking diet improves cognitive function in mice.
“FMD relieved anxiety and enhanced cognition in aged mice.”
Animals
Fasting mimicking diet extends lifespan and improves intestinal and cognitive health
Food & function
Fasting-mimicking diet improves cognitive function in humans.
“Human studies have also reported improvements in AD biomarkers, cognitive functions, and subjective well-being measures following FMDs.”
Review
Biomolecules
Fasting-mimicking diet improves cognitive function in animal models of AD.
“FMDs can reduce amyloid-beta accumulation, tau phosphorylation, and inflammation, as well as improve cognitive function in animal models of AD.”
Reviewin animal models of AD
Biomolecules
Fasting-mimicking diet improves cognitive function in mice.
“In old mice, FMD cycles promoted hippocampal neurogenesis, lowered IGF-1 levels and PKA activity, elevated NeuroD1, and improved cognitive performance”
Animals
Cell metabolism
Fat mass
downin humans3
3 studies
Fat mass
downin humans3
Fasting-mimicking diet decreases fat mass in humans.
“Concurrently, the FM and PBF decreased across all three cycle FMD (main time effect, p < 0.001, p = 0.001).”
Human trialthree cycles of the 5-day FMDfemalesn = 30
Breast cancer research and treatment
Fasting-mimicking diet decreases fat mass in cancer patients undergoing active treatment.
“while the fat mass decreased”
Human trialin cancer patients undergoing active treatment
Cancers
Fasting-mimicking diet decreases fat mass in humans (metabolically healthy women with obesity).
“Favorable effects on fat mass and muscle mass were only seen in the FMD group.”
Human trialmetabolically healthy women with obesity2 monthsfemalesn = 60
Obesity surgery
Body weight
downin humans2no changein humans1
3 studies
Body weight
downin humans2no changein humans1
Fasting-mimicking diet decreases body weight in humans (-3.79 kg (95% CI 1.97–5.61 kg)).
“On average the weight of patients’ receiving 3 FMD cycles dropped by 3.79 kg after the 3 months, within which the true reduction is likely to be between 1.97 and 5.61 kg with 95% confidence.”
Human trial3 cycles of a 4-day dietn = 29
Prostate cancer and prostatic diseases
Fasting-mimicking diet showed no clear effect on body weight in humans.
“Handgrip strength and body weight did not change throughout the study ( C and ).”
Human trial2 to 21 FMD cycles (average: 6.3 cycles per patient)n = 90
Cancers
Fasting-mimicking diet decreases body weight in humans.
“In conclusion, three cycles of the FMD reduced body weight, trunk and total body fat, blood pressure, and IGF-1 in comparison to a normal diet.”
Human trial3 monthsn = 100
Science translational medicine
Albumin-to-creatinine ratio
downin humans2no changein humans1
2 studies
Albumin-to-creatinine ratio
downin humans2no changein humans1
Fasting-mimicking diet showed no clear effect on albumin-to-creatinine ratio in humans (patients with macroalbuminuria at baseline) (434.0 (404.7, 463.4) mg/g; P = 0.23).
“but not in those with macroalbuminuria [434.0 (404.7, 463.4) mg/g; P = 0.23]”
Human trialpatients with macroalbuminuria at baselinemonthly6 monthsn = 40
The Journal of clinical endocrinology and metabolism
Fasting-mimicking diet decreases albumin-to-creatinine ratio in humans (patients with microalbuminuria at baseline) (-30.3 (-35.7, -24.9) mg/g; P ≤ 0.05).
“FMD led to a reduction of ACR in patients with microalbuminuria levels at baseline [-30.3 (-35.7, -24.9) mg/g; P ≤ 0.05]”
Human trialpatients with microalbuminuria at baselinemonthly6 monthsn = 40
The Journal of clinical endocrinology and metabolism
Fasting-mimicking diet decreases albumin-to-creatinine ratio in patients with microalbuminuria levels at baseline (−30.3 (−35.7, −24.9) mg/g, P ≤ 0.05).
“In the prespecified subgroup analysis, when compared to the control group, FMD reduced ACR [−30.3 (−35.7, −24.9) mg/g; P ≤ 0.05] in patients with microalbuminuria levels at baseline”
Human trialin patients with microalbuminuria levels at baseline6 diet cycles
The Journal of clinical endocrinology and metabolism
Fasting-mimicking diet showed no clear effect on albumin-to-creatinine ratio in humans (110.3 (99.2, 121.5) mg/g, P = 0.45).
“After 6 diet cycles, ACR did not change compared to respective baseline in both groups, and change in ACR was comparable between study groups [110.3 (99.2, 121.5) mg/g; P = 0.45].”
Human trial6 diet cyclesn = 41
The Journal of clinical endocrinology and metabolism
Fasting-mimicking diet decreases albumin-to-creatinine ratio in patients with microalbuminuria (-30.3 mg/g (95% CI -35.7, -24.9 mg/g; P≤0.05)).
“-30.3mg/g (95% CI -35.7, -24.9mg/g; P≤0.05] in patients with microalbuminuria”
Human trialin patients with microalbuminuriasix monthsn = 40
medRxivPreprint
Glucose
downin humans2−19%
2 studies
Glucose
downin humans2−19%
Fasting-mimicking diet decreases glucose in humans (4.7 mmol/L to 4.0 mmol/L).
“The plasma glucose level significantly decreased over time (p = 0.012) from the fed state 4.7 mmol/L (median, IQR 4.2–6.0) to FMD-fasted 4.0 mmol/L (median, IQR 3.63–4.35), with the most pronounced difference between overnight-fasted and FMD-fasted (p = 0.012; ).”
Human trialn = 9
Nutrients
Fasting-mimicking diet decreases glucose in humans (healthy individuals).
“FMD was associated with reduced plasma glucose and insulin-like growth factor-1 and increased ketone levels.”
Human trialhealthy individualstwo cycles of a 4-day FMD separated by 3 weeks of regular dietn = 6
Nutrients
Fasting-mimicking diet decreases glucose (-18.6%).
“In 99 evaluable patients the FMD reduced median plasma glucose concentration by 18.6% (range: −63.1%; +67.8%), serum insulin by 50.7% (range: −91.3%; +697%), and serum IGF1 by 30.3% (range: −72.3%; +139.8%), while it increased average urinary ketones from 0.18 mg/dL to 59.9 mg/dL.”
Human trialfive-day FMD followed by 16 to 23 days of refeedingn = 99
Cancer discovery
Fasting-mimicking diet decreases glucose in humans.
“resulted in a consistent decrease of blood glucose and growth factor concentration”
Human trialn = 101
Cancer discovery
Quality of life
no changein humans1upin humans1
2 studies
Quality of life
no changein humans1upin humans1
Fasting-mimicking diet showed no clear effect on quality of life in humans (unadjusted mean difference −0.04, 95% CI −0.10 to 0.03).
“Though unadjusted differences in QALYs were not statistically significant, QALYs were lower in the FMD group compared to the control group.”
Human trialone year
BMC primary care
Fasting-mimicking diet showed no clear effect on quality of life in humans (type 2 diabetes) (-0.04, 95% CI -0.10 to + 0.03).
“In the trial-based analysis (n = 92), QALYs were insignificantly lower (-0.04, 95% CI -0.10 to + 0.03)”
Human trialtype 2 diabetesmonthly 5-consecutive dayone yearn = 92
BMC primary care
Fasting-mimicking diet improves quality of life in humans (obesity hypoventilation syndrome) (p < 0.05).
“The percentage change in the MOSAS questionnaire score and PSQI questionnaire was higher in the mimic diet group than in the reflexology group.”
Human trialobesity hypoventilation syndrometwo monthsmales
Journal of complementary & integrative medicine
Muscle mass
no changein humans1upin humans1
2 studies
Muscle mass
no changein humans1upin humans1
Fasting-mimicking diet showed no clear effect on muscle mass in humans after three FMD cycles and a 21-day washout (-0.05 kg (95% CI -0.36 to 0.27)).
“while muscle mass remained stable (- 0.05 kg, 95% CI - 0.36, 0.27 kg; p = 0.270)”
Human trialafter three FMD cycles and a 21-day washoutrecipe-based34-54% of normal caloric intakethree FMD cyclesn = 27
Breast cancer research and treatment
Fasting-mimicking diet showed no clear effect on muscle mass in humans.
“Notably, the FFM and SMM remained stable across all three cycles of FMD.”
Human trialthree cycles of the 5-day FMDfemalesn = 30
Breast cancer research and treatment
Fasting-mimicking diet improves muscle mass in humans (metabolically healthy women with obesity).
“Favorable effects on fat mass and muscle mass were only seen in the FMD group.”
Human trialmetabolically healthy women with obesity2 monthsfemalesn = 60
Obesity surgery
All 193Fewer
What is fasting-mimicking diet linked with?
4Studies link fasting-mimicking diet with 4 measures, most often cancer (3 studies).
Cancer
downin reviews2downin mice1
3 studies
Cancer
downin reviews2downin mice1
Fasting-mimicking diet lowers the risk of cancer.
“reduces the incidence of cancer and other diseases in healthy individuals”
Review
The Role of Fasting-Mimicking Diet in Cancer Therapy: Mechanisms, Challenges, and Clinical Prospects
Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition
Fasting-mimicking diet lowers the risk of cancer.
“decrease the incidence of cancer and other age-related diseases”
Review
Fasting and fasting mimicking diets in cancer prevention and therapy
Trends in cancer
Fasting-mimicking diet lowers the risk of cancer in mice.
“Bi-monthly FMD cycles started at middle age extended longevity, lowered visceral fat, reduced cancer incidence and skin lesions”
Animalsbi-monthly
Cell metabolism
Neutropenia
downin humans1
1 study
Neutropenia
downin humans1
Fasting-mimicking diet lowers the risk of neutropenia in humans during neo-adjuvant chemotherapy.
“The occurrence of grade III vomiting and neutropenia in the control group was significantly higher than the FMD group (P = <0.001 and p = 0.04 respectively).”
Human trialduring neo-adjuvant chemotherapy3 days before to and on the day of each cycle of chemotherapyn = 44
Frontiers in nutrition
Immune response
upin humans1
1 study
Immune response
upin humans1
Fasting-mimicking diet is associated with immune response in humans (phase 1/2 clinical trials in patients with different tumor types).
“results of phase 1/2 clinical trials showed that cyclic FMD is safe, feasible, and associated with positive metabolic and immunomodulatory effects in patients with different tumor types”
Reviewphase 1/2 clinical trials in patients with different tumor types
Cyclic fasting-mimicking diet in cancer treatment: Preclinical and clinical evidence
Cell metabolism
Severe adverse events
downin humans1
1 study
Severe adverse events
downin humans1
Fasting-mimicking diet lowers the risk of severe adverse events (12.9% (90% CIs: 7.8–19.7%)).
“The trial met its primary endpoint, with an incidence of severe grade 3 or 4 (G3/G4) FMD-related AEs of 12.9% (90% CIs: 7.8–19.7%), that is, significantly lower than the prespecified 20% threshold.”
Human trialfive-day FMD followed by 16 to 23 days of refeedingn = 101
Cancer discovery
What acts on fasting-mimicking diet?
1Studies name lactobacillus johnsonii as acting on fasting-mimicking diet.
Lactobacillus johnsonii
is required forin mice1
1 study
Lactobacillus johnsonii
is required forin mice1
Lactobacillus johnsonii is required for fasting-mimicking diet in CRC.
“Lactobacillus. johnsonii is necessary for the anticancer process of FMD in CRC”
Animalsin CRC
Fasting-mimicking diet remodels gut microbiota and suppresses colorectal cancer progression
NPJ biofilms and microbiomes
Has fasting-mimicking diet been tested in people?
1 of 1 about agingYes: 47 trials and 2 observational studies in people have been published.
About aging
Fasting Mimicking Diet and Autophagy
Status unknown
Funding
1 grant since 2019Japan Society for the Promotion of Science¥12M
How this record changed
Summary rewritten as its findings changed.
As it read before
Fasting-mimicking diets extend mouse lifespan across independent labs, and a mouse study reports improved cognition. Independent labs also report lower BMI and HbA1c in humans, while human trials report weight loss or no weight change. Some authors work at companies including L-Nutra, and some papers declare L-Nutra ties.
Summary rewritten as its findings changed.
As it read before
A human trial in healthy people reports increased ketones and decreased IGF-1 and glucose with a fasting-mimicking diet, alongside increased HLA-DR+ T cells and TNF signaling in peripheral blood mononuclear cells. Reviews describe reduced insulin resistance and biological age in humans and lifespan extension in animals. Five findings come from one lab funded by Oncode Institute.
Summary written from the findings.